Skip to main content
Clinical Trials/DRKS00021608
DRKS00021608
Not yet recruiting
未知

A prospective randomized comparative trial to evaluate the best time-point to taper-off anticonvulsive medication after epilepsy surgery - AMARES (Anticonvulsive Medication After Resective Epilepsy Surgery)

niversitätsklinikum Göttingen Klinik für Anästhesiologie Klinik für Klinische Neurophysiologie0 sites100 target enrollmentApril 28, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
G40.2
Sponsor
niversitätsklinikum Göttingen Klinik für Anästhesiologie Klinik für Klinische Neurophysiologie
Enrollment
100
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 28, 2020
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum Göttingen Klinik für Anästhesiologie Klinik für Klinische Neurophysiologie

Eligibility Criteria

Inclusion Criteria

  • Resective epilepsy surgery
  • \- preoperative seizure frequency \= 1 seizure per month
  • \- immediate postoperative seizure freedom for at least 3 months

Exclusion Criteria

  • \- Epileptic seizures within the first 3 months after epilepsy surgery
  • \- Participation in a clinical trial on an anticonvulsive drug
  • \- Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials